Follow
Thomas G. Boyer
Thomas G. Boyer
Professor of Molecular Medicine, University of Texas Health Science Center at San Antonio
Verified email at uthscsa.edu
Title
Cited by
Cited by
Year
Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter.
Q Zhou, PM Lieberman, TG Boyer, AJ Berk
Genes & Development 6 (10), 1964-1974, 1992
4871992
Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein
TG Boyer, MED Martin, E Lees, RP Ricciardi, AJ Berk
Nature 399 (6733), 276-279, 1999
3901999
Mediator is a transducer of Wnt/β-catenin signaling
S Kim, X Xu, A Hecht, TG Boyer
Journal of Biological Chemistry 281 (20), 14066-14075, 2006
3672006
Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1
L Zheng, H Pan, S Li, A Flesken-Nikitin, PL Chen, TG Boyer, WH Lee
Molecular cell 6 (4), 757-768, 2000
3112000
BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor
L Zheng, LA Annab, CA Afshari, WH Lee, TG Boyer
Proceedings of the National Academy of Sciences 98 (17), 9587-9592, 2001
2952001
Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation
N Ding, H Zhou, PO Esteve, HG Chin, S Kim, X Xu, SM Joseph, MJ Friez, ...
Molecular cell 31 (3), 347-359, 2008
2662008
Lessons learned from BRCA1 and BRCA2
L Zheng, S Li, TG Boyer, WH Lee
Oncogene 19 (53), 6159-6175, 2000
2382000
A class of activation domains interacts directly with TFIIA and stimulates TFIIA-TFIID-promoter complex assembly
N Kobayashi, TG Boyer, AJ Berk
Molecular and Cellular Biology 15 (11), 6465-6473, 1995
2361995
Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-κB
LD Kerr, LJ Ransone, P Wamsley, MJ Schmitt, TG Boyer, Q Zhou, AJ Berk, ...
Nature 365 (6445), 412-419, 1993
1961993
Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts
Q Zhong, TG Boyer, PL Chen, WH Lee
Cancer research 62 (14), 3966-3970, 2002
1922002
Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment
Q Yang, M Ciebiera, MV Bariani, M Ali, H Elkafas, TG Boyer, A Al-Hendy
Endocrine reviews 43 (4), 678-719, 2022
1692022
Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity
M Turunen, JM Spaeth, S Keskitalo, MJ Park, T Kivioja, AD Clark, ...
Cell reports 7 (3), 654-660, 2014
1652014
Mediator modulates Gli3-dependent Sonic hedgehog signaling
H Zhou, S Kim, S Ishii, TG Boyer
Molecular and cellular biology 26 (23), 8667-8682, 2006
1482006
Mediator kinase module and human tumorigenesis
AD Clark, M Oldenbroek, TG Boyer
Critical reviews in biochemistry and molecular biology 50 (5), 393-426, 2015
1412015
Factors (TAFs) required for activated transcription interact with TATA box-binding protein conserved core domain.
Q Zhou, TG Boyer, AJ Berk
Genes & development 7 (2), 180-187, 1993
1311993
Mediator and human disease
JM Spaeth, NH Kim, TG Boyer
Seminars in cell & developmental biology 22 (7), 776-787, 2011
1172011
Mutations in MED12 cause X-linked Ohdo syndrome
AT Vulto-van Silfhout, BBA De Vries, BWM Van Bon, A Hoischen, ...
The American Journal of Human Genetics 92 (3), 401-406, 2013
1082013
Functional interaction of adenovirus E1A with holo-TFIID.
TG Boyer, AJ Berk
Genes & development 7 (9), 1810-1823, 1993
1031993
MED19 and MED26 are synergistic functional targets of the RE1 silencing transcription factor in epigenetic silencing of neuronal gene expression
N Ding, C Tomomori-Sato, S Sato, RC Conaway, JW Conaway, TG Boyer
Journal of biological chemistry 284 (5), 2648-2656, 2009
962009
Mutations in Exon 1 Highlight the Role of MED12 in Uterine Leiomyomas
K Kämpjärvi, MJ Park, M Mehine, NH Kim, AD Clark, R Bützow, T Böhling, ...
Human mutation 35 (9), 1136-1141, 2014
892014
The system can't perform the operation now. Try again later.
Articles 1–20